In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
about
Escherichia coli β-Lactamases: What Really MattersInsight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics studyCTX-M Enzymes: Origin and Diffusion.A Comparison of Methods to Measure Fitness in Escherichia coli.Avibactam and inhibitor-resistant SHV β-lactamasesAntibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases worldA Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.Plasmidome-analysis of ESBL-producing escherichia coli using conventional typing and high-throughput sequencing.Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery.CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate.Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains.Controlling resistant bacteria with a novel class of β-lactamase inhibitor peptides: from rational design to in vivo analyses.Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate.In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity.Fluoroquinolone levels in healthy dog urine following a 20-mg/kg oral dose of enrofloxacin exceed mutant prevention concentration targets against Escherichia coli isolated from canine urinary tract infections.Genetic and Functional Characterization of blaCTX-M-199, a Novel Tazobactam and Sulbactam Resistance-Encoding Gene Located in a Conjugative mcr-1-Bearing IncI2 Plasmid.Defining substrate specificity in the CTX-M family: the role of Asp240 in ceftazidime hydrolysis.
P2860
Q26749590-53C82607-D48E-4185-8418-2FF5C4174EC6Q28542531-BBCA7941-5DC9-4F38-BE61-5EDBD0BBFCEBQ30415141-36F2F389-6FD0-4642-BCE1-FD85EEDA3E8CQ35626718-F2EBB48B-3231-46F8-A4D4-DAF5E3E82503Q35746285-BE0509B7-A150-47E9-BB1B-BA7F7F10217EQ36595848-53034D58-1E53-4986-92EB-30BFB78DAD43Q36630989-316F1DB7-0A5B-4638-B25A-DAEE10559DEBQ36926956-4F2AF145-3806-444B-922D-8F601E6C8D68Q36957667-1129D5D1-0328-42C1-BE60-51DDECD997E3Q37538628-2C5E48F9-1FE7-4705-9B41-4F7C8A28ADE1Q37546694-F125BF7A-4DFA-4BFA-8B24-FB7AF1B6FF1FQ38967477-08D5E0BF-F116-4EA3-BE70-1915921B777CQ40163436-05C2B009-1CD0-4D23-B31F-F4A1C1F183B7Q42048932-B6408333-1B26-4033-BC95-A43AB57C3E65Q45796073-431C11AB-D748-4124-8A46-5D466CC6CAB8Q49701622-5E9749CA-8C92-4DEB-9A34-A4F68075CF6CQ53697061-0C6CBB9B-8D67-4E1A-8F08-C9DCB891C00A
P2860
In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vitro selection of variants ...... edicting the in vivo scenario?
@en
type
label
In vitro selection of variants ...... edicting the in vivo scenario?
@en
prefLabel
In vitro selection of variants ...... edicting the in vivo scenario?
@en
P2093
P2860
P356
P1476
In vitro selection of variants ...... edicting the in vivo scenario?
@en
P2093
Aida Ripoll
Angela Novais
Fernando Baquero
Juan-Carlos Galán
Maria-Carmen Turrientes
Mario J Rodríguez-Domínguez
Rafael Cantón
P2860
P304
P356
10.1128/AAC.00178-11
P407
P577
2011-07-25T00:00:00Z